Phase 4 Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with primary Sjögren's syndrome (pSS) based on the 2016 international classification criteria for this condition.
- People who experience symptoms of dry mouth and dry eyes.
- People whose blood test at the screening stage shows a positive result for a specific antibody called anti-SSA/Ro-60.
- People whose blood test shows a protein called IgG at a level of 16 g/L or higher.
- People who have not taken hormones, immunosuppressants, biological medicines, or similar treatments in the 4 weeks before screening.
- Women whose pregnancy test result is negative at screening, and who agree to use effective contraception throughout the trial.
- People who have not taken part in any other drug trial in the 12 weeks before joining.
Who may not be able to join:
- Women who are pregnant, breastfeeding, or planning to become pregnant during the study.
- People who have another connective tissue disease alongside their Sjögren's syndrome.
- People who have or have had a cancer diagnosis.
- People with a mental illness, a history of alcohol or drug/substance misuse, a weakened immune system, or an infection that is not under control.
- People whose condition requires additional strong medications to manage, or who have serious involvement of major organs — such as the heart, liver, kidneys, lungs, or blood — with specific abnormal test results in those areas (confirm with trial site for exact thresholds).
- People who have lesions affecting the back of the eye or visual field.
- People who have a known allergy to any ingredient in the study medicines (IGU and/or HCQ).
- People whom the trial investigator considers unsuitable for the study for any reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yongmei Han, Sir Run Run Shaw Hospital
Phone: 13858121751
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The change of SSRI-30 between the two groups at 24 weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.